Trilipix is a prescription drug approved for the treatment of high triglyceride and cholesterol levels. This eMedTV article describes how the drug works, explains when and how to take it, lists some of the possible side effects, and more.
Common side effects of Trilipix include arm or leg pain, headaches, and dizziness. This eMedTV Web page lists other common side effects, as well as some of the less common but potentially serious problems that require immediate medical attention.
This eMedTV segment explains that there is a link between muscle pain and Trilipix (fenofibric acid) use, but it isn't usually a cause for concern. However, if muscle pain and weakness occurs with a fever or you feel ill, seek medical attention.
Trilipix is a medication that can treat unhealthy cholesterol and triglyceride levels. This eMedTV segment explains these uses of Trilipix in more detail, discusses possible off-label reasons, and addresses using the drug in children.
The recommended starting dose of Trilipix for most people with high cholesterol is 135 mg once daily. This eMedTV page also provides dosing guidelines for the treatment of severely high triglycerides and offers tips to ensure a safe treatment process.
If Trilipix is taken with warfarin, cyclosporine, or bile acid sequestrants, drug interactions may occur. This eMedTV segment lists specific products from these drug classes and explains what problems may occur as a result of Trilipix interactions.
You should not take Trilipix if you have gallbladder disease. This eMedTV resource offers more warnings and precautions for Trilipix, including information on side effects that may occur and a list of people who should not take the drug.
As with any medication, it is possible to take too much Trilipix (fenofibric acid). This article from the eMedTV library explores the potential effects of a Trilipix overdose and describes some of the common treatment options that are available.
The full risks of using Trilipix (fenofibric acid) during pregnancy are not known at this time. This eMedTV Web page offers more information on this important topic and explains what problems occurred when a similar drug was given to animals.
Currently, breastfeeding women are advised to avoid taking Trilipix (fenofibric acid). This eMedTV article offers a more in-depth look at breastfeeding while taking this drug, and explains what problems may occur if an infant is exposed to Trilipix.
At this time, Trilipix (fenofibric acid) is not available in generic form. As this article from the eMedTV site explains, the earliest predictable date that generic Trilipix could become available is January 2025, when the patent for the drug expires.
